Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (64)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Chen, B.
Right arrow Articles by You, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, B.
Right arrow Articles by You, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 Oxford University Press

research-article

Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors

Bin Chen, Lili Liu 1, Andre Castonguay 1, Robert R. Maronpot 2, Marshall W. Anderson 2 and Ming You 3

Department of Pathology, Medical College of Ohio Toledo, OH 43699, USA
1Laboratory of Cancer Etiology and Chemoprevention, School of Pharmacy, Laval University Quebec City, Canada G1K 7P4
2National Institute of Environmental Health Sciences Research Triangle Park, NC 27709, USA

3To whom correspondence should be addressed

In a previous study, the spectrum of H-ras mutations detected in B6C3F1 mouse liver tumors induced by 5, 50 or 150 µmol/kg body wt of N-nitrosodiethylamine (NDEA) was similar to that in spontaneous B6C3F1 mouse liver tumors, suggesting that activation of the H-ras gene in NDEA-Induced mouse liver tumors may not be the direct result of the chemical interaction with the H-ras gene. In the present study, mutations in the H-ras oncogene from B6C3F1 mouse liver tumors induced by 5 or 50 µmol/kg body wt of NDEA were characterized by DNA amplification with polymerase chain reaction (PCR), single-strand conformation polymorphism (SSCP) and direct sequence analysis. Twenty-one of 66 NDEA-induced B6C3F1 mouse liver tumors contained activated H-ras gene with 2 of 21 having a CG to AT transversion at the first base of codon 61, 17 of 21 having AT to GC transition and 2 of 21 having an AT to TA transversion at the second base of codon 61 in the H-ras gene. The predominant mutation, AT to GC transition (17/21, 81%) is consistent with the formation of O4-ethylthymine adduct, and is distinct from the predominant CG to AT transversion (50%) at the first base of codon 61 detected in H-ras gene from NDEA-induced B6C3F1 mouse liver tumors in a previous study by Stowers et al. Mutations in the K-ras oncogene from 59 A/J mouse lung tumors induced by 0.53 mmol/kg body wt of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) were also characterized by using the above mentioned methods. Forty-six of 59 NNK-induced A/J mouse lung tumors contained activated K-ras genes. All 46 (100%) of the activated K-ras gene had GC to AT transitions at the second base of codon 12. The same mutation was observed in 70% (7/10) of the K-ras oncogene from A/J lung tumors induced by 4.8 mmol/kg body wt (given in 21 doses) of NNK. These data suggest that other factors in addition to genotoxic effect might be involved in the induction of rodent tumors by some carcinogens when given at higher doses. Therefore, further studies to compare the dose-dependent differences in the profile of ras mutations induced by chemical carcinogens may help to assess human cancer risk. Mutation(s) in exons 5-8 of the p53 gene was not found in these NDEA-induced mouse liver tumors and NNK-induced mouse lung tumors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
I.A. Lea, M.A. Jackson, X. Li, S. Bailey, S.D. Peddada, and J.K. Dunnick
Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns
Carcinogenesis, September 1, 2007; 28(9): 1851 - 1858.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
B. I. Ghanayem
Inhibition of Urethane-Induced Carcinogenicity in Cyp2e1-/- in Comparison to Cyp2e1+/+ Mice
Toxicol. Sci., February 1, 2007; 95(2): 331 - 339.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. A. Jackson, I. Lea, A. Rashid, S. D. Peddada, and J. K. Dunnick
Genetic Alterations in Cancer Knowledge System: Analysis of Gene Mutations in Mouse and Human Liver and Lung Tumors
Toxicol. Sci., April 1, 2006; 90(2): 400 - 418.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
R. Meuwissen and A. Berns
Mouse models for human lung cancer
Genes & Dev., March 15, 2005; 19(6): 643 - 664.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Yang, Z. Zhang, A. B. Mukherjee, and R. I. Linnoila
Increased Susceptibility of Mice Lacking Clara Cell 10-kDa Protein to Lung Tumorigenesis by 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, a Potent Carcinogen in Cigarette Smoke
J. Biol. Chem., July 9, 2004; 279(28): 29336 - 29340.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
G. M. Williams, M. J. Iatropoulos, and A. M. Jeffrey
Thresholds for the Effects of 2-Acetylaminofluorene in Rat Liver
Toxicol Pathol, February 1, 2004; 32(2_suppl): 85 - 91.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
G. M. Williams, M. J. Iatropoulos, and A. M. Jeffrey
Mechanistic Basis for Nonlinearities and Thresholds in Rat Liver Carcinogenesis by the DNA-Reactive Carcinogens 2-Acetylaminofluorene and Diethylnitrosamine
Toxicol Pathol, May 1, 2000; 28(3): 388 - 395.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
S. Frey, A. Buchmann, W. Bursch, R. Schulte-Hermann, and M. Schwarz
Suppression of apoptosis in C3H mouse liver tumors by activated Ha-ras oncogene
Carcinogenesis, February 1, 2000; 21(2): 161 - 166.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S.-J. C. Wei, R. L. Chang, K. A. Merkler, M. Gwynne, X. X. Cui, B. Murthy, M.-T. Huang, J.-G. Xie, Y.-P. Lu, Y.-R. Lou, et al.
Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene
Carcinogenesis, September 1, 1999; 20(9): 1689 - 1696.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. S. Tam, J. F. Foley, T. R. Devereux, R. R. Maronpot, and T. E. Massey
High Frequency and Heterogeneous Distribution of p53 Mutations in Aflatoxin B1-induced Mouse Lung Tumors
Cancer Res., August 1, 1999; 59(15): 3634 - 3640.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Liu, X. Qin, and S. L. Gerson
Reduced lung tumorigenesis in human methylguanine DNA—methyltransferase transgenic mice achieved by expression of transgene within the target cell
Carcinogenesis, February 1, 1999; 20(2): 279 - 284.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
G. L. Finch, T. H. March, F. E. Hahn, E. B. Barr, S. A. Belinsky, M. D. Hoover, J. E. Lechner, K. J. Nikula, and C. H. Hobbs
Carcinogenic Responses of Transgenic Heterozygous p53 Knockout Mice to Inhaled 239PuO2 or Metallic Beryllium
Toxicol Pathol, July 1, 1998; 26(4): 484 - 491.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
W.H. Butler
A Review of the Hepatic Tumors Related to Mixed-Function Oxidase Induction in the Mouse
Toxicol Pathol, July 1, 1996; 24(4): 484 - 492.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.